Bionic eye commercialisation with Dr Ash Attia

A bionic eye implant might, at one stage, have seemed like something out of a science fiction movie.  

Not anymore.  

An Australian bionic eye shows promise of giving functional vision back to people who have lost their sight due to a genetic condition called retinitis pigmentosa. 

Being developed by Bionic Vision Technology (BVT), the bionic eye system came out of research at the Bionics Institute, the Centre for Eye Research Australia (CERA), CSIRO and ANU.  

In this episode of Med Tech Talks, Robert Klupacs is joined by BVT CEO Dr Ash Attia to discuss the research commercialisation journey of the bionic eye, and the upcoming large-scale clinical trials of this revolutionary technology. 

In this episode you will hear about:

• When will the bionic eye be available to patients?  
• Ash's insights on the difference between good and great companies
• Advice on how entrepreneurs should build a company to have lasting success.

More information:

Learn more about Bionic Vision Technologies.

Find out more about Dr Ash Attia and his team at BVT.

Learn about the development of Australia's Bionic eye.

Updated version 05/08/22